based on 4 analysts
80.00%
Buy
0.00%
Hold
20.00%
Sell
Based on 4 analysts offering long term price targets for Sanofi India Ltd. An average target of ₹8176.25
Source: S&P Global Market Intelligence
Sanofi India Ltd price forecast by 4 analysts
Upside of14.40%
High
₹9345
Target
₹8176.25
Low
₹7560
Sanofi India Ltd target price ₹8176.25, a slight upside of 14.4% compared to current price of ₹7177.55. According to 4 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Sanofi India Ltd revenue growth forecast
Expected growth rate Q1, FY2026:0
Forecast
Actual
Including amortisation and stock based compensations
Sanofi India Ltd EPS growth forecast
EPS estimate Q1, FY2026:0
Forecast
Actual
Source: S&P Global Market Intelligence
Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | + 6.16 % |
3 Month Return | -0.61 % |
1 Year Return | + 0.27 % |
Market Stats | |
Previous Close | ₹7,146.90 |
Open | ₹7,150.00 |
Volume | 16.14K |
Upper Circuit | - |
Lower Circuit | - |
Market Cap | ₹16,459.31Cr |
P/E Ratio | 31.09 |
PEG Ratio | 0.33 |
Market Cap | ₹16,459.31 Cr |
P/B Ratio | 18.27 |
EPS | 262.13 |
Dividend Yield | 2.07 |
Sector | Pharmaceuticals |
ROE | 52.65 |
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
BUY | ₹16,459.31 Cr | 5.22% | 0.52 | ₹602 Cr | ₹2,851 Cr | |
BUY | ₹90,184.74 Cr | 30.78% | 0.56 | ₹3,168 Cr | ₹29,001 Cr | |
HOLD | ₹1,08,668.24 Cr | 70.73% | 0.64 | ₹3,854 Cr | ₹19,547 Cr | |
BUY | ₹59,038.98 Cr | 36.49% | 0.53 | NA | NA | |
BUY | ₹47,286.31 Cr | 20% | 0.56 | ₹589 Cr | ₹3,453 Cr |
Organisation | Sanofi India Ltd |
Headquarters | |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Key events for Sanofi India Ltd
Sanofi Healthcare India has reached a settlement with Panacea Biotec regarding a patent infringement dispute over a hexavalent vaccine. Sanofi will not launch its Shan6 vaccine in India and will withdraw its patent oppositions against Panacea's vaccine.
Sanofi Settles Vaccine Patent Dispute in India - 16 Sep, 2024
Sanofi has agreed not to launch its competing vaccine, Shan6, in India and will withdraw patent oppositions against Panacea Biotec's hexavalent vaccine, signaling a resolution in their dispute.
Sanofi India Reports Decline Amid Yearly Gains - 13 Sep, 2024
Sanofi India shares fell nearly 1% despite a 35% year-to-date surge. Q1 FY25 net profit declined 16% YoY to Rs 103.2 crore, with revenue down 10% to Rs 463.5 crore.
Sanofi India Ltd Continues Upward Trend - 04 Sep, 2024
Sanofi India Ltd has risen for the fifth consecutive session, trading at Rs 7265.05, up 1.86% today. The stock has gained 13.34% in the last month, despite a decline in the benchmark NIFTY. Its PE ratio stands at 33.42 based on TTM earnings.
Sanofi India Announces Management Change - 30 Aug, 2024
Sanofi India Limited announced the cessation of Cyrus Aibara as Senior Director of Diabetes effective August 30, 2024. The company appreciates his contributions and has appointed Suresh Babu as his successor.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Retail Holding Up
Retail Investor have increased holdings from 10.41% to 11.00% in Jun 2024 quarter
Against Peers
In the last 1 year, Torrent Pharmaceuticals Ltd has given 78.3% return, outperforming this stock by 78.0%
Promoter Holding Unchanged
Promoters holdings remained unchanged at 60.40% of holdings in Jun 2024 quarter
Against Peers
In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 142.7% return, outperforming this stock by 151.4%
FII Holding Down
Foreign Institutions have decreased holdings from 6.11% to 5.81% in Jun 2024 quarter
Price Dip
In the last 6 months, SANOFI stock has moved down by -6.9%
MF Holding Down
Mutual Funds have decreased holdings from 11.67% to 11.59% in Jun 2024 quarter
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 60.4% | 0.00 | |
Foreign Institutions | 5.81% | ||
Mutual Funds | 11.59% | ||
Retail Investors | 11% | 5.61 | |
Others | 11.2% |
Sanofi India Ltd in the last 5 years
Lowest (0.00x)
December 29, 2023
Today (31.09x)
September 18, 2024
Industry (58.50x)
September 18, 2024
Highest (42.25x)
June 12, 2024
Sanofi India Ltd’s net profit fell -16.03% since last year same period to ₹103.20Cr in the Q1 2024-2025. On a quarterly growth basis, Sanofi India Ltd has generated -24.45% fall in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending December 2023, Sanofi India Ltd has declared dividend of ₹117 - translating a dividend yield of 7.61%.
Read More about DividendsBearish
Neutral
Bullish
Sanofi India Ltd is currently in a Bullish trading position according to technical analysis indicators.
Sanofi India Ltd (SANOFI) share price today is ₹7177.55
Sanofi India Ltd is listed on NSE
Sanofi India Ltd is listed on BSE
PE Ratio of Sanofi India Ltd is 31.09
PE ratio = Sanofi India Ltd Market price per share / Sanofi India Ltd Earnings per share
Today’s traded volume of Sanofi India Ltd(SANOFI) is 16.14K.
Today’s market capitalisation of Sanofi India Ltd(SANOFI) is ₹16459.31Cr.
Sanofi India Ltd(SANOFI | Price |
---|---|
52 Week High | ₹10524.95 |
52 Week Low | ₹5892.8 |
Sanofi India Ltd(SANOFI) share price is ₹7177.55. It is down -31.80% from its 52 Week High price of ₹10524.95
Sanofi India Ltd(SANOFI) share price is ₹7177.55. It is up 21.80% from its 52 Week Low price of ₹5892.8
Sanofi India Ltd(SANOFI | Returns |
---|---|
1 Day Returns | 30.65% |
1 Month Returns | 6.16% |
3 Month Returns | -0.61% |
1 Year Returns | 0.27% |